Search Result "monoclonal antibodydrug."
HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007
Protein Kinases as Tumor Biomarkers and Therapeutic Targets
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4209-4225
Author(s): Chuntao Quan,Juanjuan Xiao,Lin Liu,Qiuhong Duan,Ping Yuan,Feng Zhu
Cell Surface Markers and their Targeted Drugs in Breast Cancer
Journal: Current Protein & Peptide Science
Volume: 23 Issue: 5 Year: 2022 Page: 335-346
Author(s):
A Neutralization scFv Antibody against IL-1β Isolated from a NIPA-based Bacterial Display Library
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 6 Year: 2013 Page: 571-581
Author(s): Tianhe Li,Liming Xu,Guiping Ren,Chengkai Yin,Bing Zhou,Xianlong Ye,Qingcui Li,Ning Li,Deshan Li
ADCs, as Novel Revolutionary Weapons for Providing a Step Forward in Targeted Therapy of Malignancies
Journal: Current Drug Delivery
Volume: 17 Issue: 1 Year: 2020 Page: 23-51
Author(s): Nooshafarin Amani,Farid Abedin Dorkoosh,Hamid Mobedi
Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond
Journal: Current Drug Targets
Volume: 16 Issue: 10 Year: 2015 Page: 1021-1030
Author(s): Urpo Lamminmaki,Dimitar Nikolov,Juha Himanen
Immunotherapy-Associated Hypophysitis under Anti-PD1: Two CaseReports
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 7 Year: 2023 Page: 996-1004
Author(s):
Privileged Scaffolds in Drug Discovery against Human Epidermal Growth FactorReceptor 2 for Cancer Treatment
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 44 Year: 2023 Page: 3563-3578
Author(s):
Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 2007-2015
Author(s):
Influence of Nano-Particulate Impurities and β-glucans on the Stability ofProtein-Based Formulations
Journal: Current Drug Delivery
Volume: 21 Issue: 0 Year: 2024 Page: 1-7
Author(s):